{"id":"W2152106583","doi":"10.1111/j.1610-0387.2006.06111.x","title":"CLinical Experience Acquired with Raptiva<sup>®</sup> (CLEAR) trial in patients with moderate‐to‐severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo‐controlled trial","year":2006,"lang":"en","type":"article","venue":"JDDG Journal der Deutschen Dermatologischen Gesellschaft","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Efalizumab; Medicine; Psoriasis Area and Severity Index; Placebo; Clinical trial; Open label; Plaque psoriasis; Psoriasis; Randomized controlled trial; Internal medicine; Adverse effect; Refractory (planetary science); Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003740744,0.0008412492,0.001917181,0.0001867523,0.0003371846,0.0008590525,0.0005732458,0.001047252,0.003640937],"category_scores_gemma":[0.00189935,0.0003492073,0.001294957,0.0002762224,0.0006618801,0.0007735791,0.0003143321,0.002211434,0.0005908149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002773307,"about_ca_system_score_gemma":0.000557009,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000320591,"about_ca_topic_score_gemma":0.0006505945,"domain_scores_codex":[0.9987294,0.0008885089,0.00007316035,0.0001186132,0.00008754143,0.0001028078],"domain_scores_gemma":[0.9985619,0.0004251762,0.0004289842,0.0001429806,0.00009005325,0.0003507687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8482829,0.01092239,0.004544509,0.002827203,0.002160458,0.0002050028,0.0002743261,0.0006782467,0.01011877,0.0003162042,0.003526998,0.1161431],"study_design_scores_gemma":[0.8235764,0.154873,0.01590693,0.0001844054,0.0008058377,0.0003497674,0.00004667512,0.0003823892,0.0007294474,0.0001769514,0.00294298,0.00002515049],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9680166,0.02366303,0.0006384547,0.0006832157,0.0001527599,0.001481995,0.0007583226,0.0001115035,0.004494136],"genre_scores_gemma":[0.9849702,0.006817973,0.001697342,0.0013598,0.0003839206,0.002011898,0.001189505,0.00002158194,0.001547816],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003740744,"threshold_uncertainty_score":0.0197832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02832144192445271,"score_gpt":0.3036950582499319,"score_spread":0.2753736163254792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}